par Piccart-Gebhart, Martine
Référence Journal of clinical oncology, 32, 4, page (347-354)
Publication Publié, 2014-02
Référence Journal of clinical oncology, 32, 4, page (347-354)
Publication Publié, 2014-02
Article révisé par les pairs
Titre: |
|
Auteur: | Piccart-Gebhart, Martine |
Informations sur la publication: | Journal of clinical oncology, 32, 4, page (347-354) |
Statut de publication: | Publié, 2014-02 |
Sujet CREF: | Sciences bio-médicales et agricoles |
MeSH keywords: | Antineoplastic Agents |
Awards and Prizes | |
Breast Neoplasms -- drug therapy -- metabolism -- pathology | |
Clinical Trials as Topic -- economics -- ethics -- trends | |
Commerce -- trends | |
Drug Industry -- trends | |
Drugs, Investigational | |
Europe | |
Female | |
Great Britain | |
Humans | |
Information Dissemination | |
International Cooperation | |
Karnofsky Performance Status | |
Leadership | |
Male | |
Multicenter Studies as Topic -- economics -- ethics -- trends | |
Neoplasms -- drug therapy | |
Patient-Centered Care -- standards -- trends | |
Public Health -- trends | |
Research Design -- trends | |
Research Personnel -- standards | |
Research Support as Topic -- economics -- ethics -- trends | |
Tumor Markers, Biological | |
United States | |
Universities | |
Note générale: | SCOPUS: ar.j |
Langue: | Anglais |
Identificateurs: | urn:issn:0732-183X |
info:doi/10.1200/JCO.2013.53.2549 | |
info:pii/JCO.2013.53.2549 | |
info:scp/84897019242 | |
info:pmid/24366941 |